Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2009

01-06-2009 | IM - Original

Usefulness of procalcitonin for diagnosis of infective endocarditis

Authors: Matjaz Jereb, Tadeja Kotar, Tomaz Jurca, Tatjana Lejko Zupanc

Published in: Internal and Emergency Medicine | Issue 3/2009

Login to get access

Abstract

The aim of this study was to evaluate the accuracy of procalcitonin (PCT) in predicting infective endocarditis (IE). 23 adult patients with IE, 30 patients with sepsis and 30 with tick-borne encephalitis were included in this prospective study. The PCT serum level, C-reactive protein (CRP), total leukocyte, and immature polymorphonuclear (PMN) cell counts were determined on admission, prior to the institution of antibiotic therapy, and compared according to the diagnosis. The median PCT level in patients with IE endocarditis was 0.81 ng/ml, in patients with sepsis it was 43.74 ng/ml, and in the group with viral infection it was 0.25 ng/ml (P < 0.001). The highest PCT level was found in patients with Staphylococcus aureus endocarditis. The area under the receiver operating characteristic curve that used PCT to predict IE was 0.722 (95% CI 0.572–0.873), compared with 0.909 (95% CI 0.829–0.989) for CRP, 0.699 (95% CI 0.551–0.846) for immature PMN cell count, and 0.619 (95% CI 0.468–0.770) for leukocyte count. Our study fails to demonstrate superiority of PCT as a diagnostic laboratorial parameter in predicting IE compared to CRP.
Literature
1.
2.
go back to reference Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81PubMedCrossRef Hoen B, Alla F, Selton-Suty C et al (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75–81PubMedCrossRef
3.
go back to reference Berlin JA, Abrutyn E, Strom BL et al (1995) Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol 76:933–936PubMedCrossRef Berlin JA, Abrutyn E, Strom BL et al (1995) Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol 76:933–936PubMedCrossRef
4.
go back to reference Hogevik H, Olaison L, Andersson R, Linberg J, Alestig K (1995) Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 74:324–339CrossRef Hogevik H, Olaison L, Andersson R, Linberg J, Alestig K (1995) Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore) 74:324–339CrossRef
5.
go back to reference Lejko-Zupanc T, Koželj M, Pikelj F (1994) Novejši pogledi na patogenezo, epidemiologijo, klinično sliko in diagnostiko infekcijskega endokarditisa. Med Razgl 33:501–508 Lejko-Zupanc T, Koželj M, Pikelj F (1994) Novejši pogledi na patogenezo, epidemiologijo, klinično sliko in diagnostiko infekcijskega endokarditisa. Med Razgl 33:501–508
6.
go back to reference Durack DT, Lukes AS, Bright DK (1994) Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96:200–208PubMedCrossRef Durack DT, Lukes AS, Bright DK (1994) Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96:200–208PubMedCrossRef
7.
go back to reference Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef
8.
go back to reference de Werra I, Jaccard C, Corradin SB et al (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613PubMedCrossRef de Werra I, Jaccard C, Corradin SB et al (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613PubMedCrossRef
9.
go back to reference Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R (2000) Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26:S148–S152PubMed Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R (2000) Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26:S148–S152PubMed
10.
go back to reference Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76–84PubMedCrossRef Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76–84PubMedCrossRef
11.
go back to reference Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP (2004) Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109:1707–1710PubMedCrossRef Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP (2004) Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109:1707–1710PubMedCrossRef
12.
go back to reference Watkin RW, Harper LV, Vernallis AB et al (2007) Pro-inflamatory cytokines IL-6, TNF-α, IL 1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect 55:220–225PubMedCrossRef Watkin RW, Harper LV, Vernallis AB et al (2007) Pro-inflamatory cytokines IL-6, TNF-α, IL 1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J Infect 55:220–225PubMedCrossRef
13.
go back to reference Cuculi F, Toggweiler S, Auer M, Auf der Maur C, Zuber M, Erne P (2008) Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis. Eur J Clin Microbiol Infect Dis 27:1145–1149PubMedCrossRef Cuculi F, Toggweiler S, Auer M, Auf der Maur C, Zuber M, Erne P (2008) Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis. Eur J Clin Microbiol Infect Dis 27:1145–1149PubMedCrossRef
14.
go back to reference ACC/AHA (2006) Guidelines for the management of patients with valvular heart disease. Circulation 114:e84–e231CrossRef ACC/AHA (2006) Guidelines for the management of patients with valvular heart disease. Circulation 114:e84–e231CrossRef
15.
go back to reference Bone RC, Balk RA, Cerra FB et al (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB et al (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMedCrossRef
16.
go back to reference Hofmann H, Heinz FX, Dippe H (1983) ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results. Zbl Bakt Hyg 255:448–455 Hofmann H, Heinz FX, Dippe H (1983) ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results. Zbl Bakt Hyg 255:448–455
17.
go back to reference Meisner M (2000) Procalcitonin (PCT). A new, innovative infection parameter. Biochemical and clinical aspect. Georg Thieme Verlag, Stuttgart Meisner M (2000) Procalcitonin (PCT). A new, innovative infection parameter. Biochemical and clinical aspect. Georg Thieme Verlag, Stuttgart
18.
go back to reference Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB (1991) Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 18:391–397PubMedCrossRef Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB (1991) Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 18:391–397PubMedCrossRef
19.
go back to reference Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J (1996) Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 77:403–407PubMedCrossRef Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J (1996) Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 77:403–407PubMedCrossRef
20.
go back to reference Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331–333PubMed Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331–333PubMed
21.
go back to reference Jereb M, Muzlovič I, Hojker S, Strle F (2001) Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 29:209–212PubMedCrossRef Jereb M, Muzlovič I, Hojker S, Strle F (2001) Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 29:209–212PubMedCrossRef
22.
go back to reference Assicot M, Gendrel D, Carsin H, Rajmond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518PubMedCrossRef Assicot M, Gendrel D, Carsin H, Rajmond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518PubMedCrossRef
23.
go back to reference Jereb M, Kotar T (2006) Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia. Wien Klin Wochenschr 118:170–174PubMedCrossRef Jereb M, Kotar T (2006) Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia. Wien Klin Wochenschr 118:170–174PubMedCrossRef
24.
go back to reference Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subject. J Clin Endocrinol Metab 79:1605–1608PubMedCrossRef Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subject. J Clin Endocrinol Metab 79:1605–1608PubMedCrossRef
25.
go back to reference Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434–436PubMedCrossRef Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434–436PubMedCrossRef
Metadata
Title
Usefulness of procalcitonin for diagnosis of infective endocarditis
Authors
Matjaz Jereb
Tadeja Kotar
Tomaz Jurca
Tatjana Lejko Zupanc
Publication date
01-06-2009
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 3/2009
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-009-0245-4

Other articles of this Issue 3/2009

Internal and Emergency Medicine 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.